2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000...

Preview:

Citation preview

2,500

3,000

3,500

4,000

4,500

5,000

5,500

6,000

2,500

3,000

3,500

4,000

4,500

5,000

5,500

6,000

Figure 1. Number of Tuberculosis Cases: California, 1930-2007

Nu

mb

er o

f T

ub

ercu

losi

s C

ases

1980 19921982 1984 1986 1988 1996 1998 2000 2002 200419941990 2006

0

2,000

4,000

6,000

8,000

10,000

12,000

1930 1940 1950 1960 1970 1980

Year

Figure 2. Number of Tuberculosis Cases and Case Rates: California, 1998-2007

0

1,000

2,000

3,000

4,000

5,000

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007

Year

0

5

10

15

20

Nu

mb

er o

f C

ases

Cas

e R

ate

per

100

,000

Number of CasesCase Rate per 100,000 Population

Figure 3. Tuberculosis Cases by Race/Ethnicity: California, 2007

Asian/Pacific Islander1,262 (46.3%)

Hispanic993 (36.4%)

Unknown10 (0.4%)

Black 217 (8.0%)

American Indian/Alaska Native

6 (0.2%)

White237 (8.7%)

Figure 4. Tuberculosis Case Rates by Race/Ethnicity: California, 1998-2007

0

5

10

15

20

25

30

35

40

45

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007

Year

Cas

es p

er 1

00,0

00

Asian/Pacific Islander

Black

Hispanic

American Indian/Alaska Native

White

0

500

1,000

1,500

2,000

2,500

3,000

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007

40

50

60

70

80

U.S.-born Foreign-born Percent Foreign-born

Figure 5. Tuberculosis Cases in Foreign-born and U.S.-born Persons: California, 1998-2007

Nu

mb

er o

f C

ases

Per

cen

t o

f C

ases

Figure 6. Tuberculosis Cases by Country of Origin: California, 2007

U.S.-born590 (21.7%)

Foreign-born2,113 (77.5%)

Unknown22 (0.8%)

Philippines477 (22.6%)

Mexico603 (28.5%)

All Others776 (36.7%)

Vietnam257 (12.2%)

Figure 7. Tuberculosis Cases in Persons 0-4 Years of Age: California, 1998-2007

0

20

40

60

80

100

120

140

160

180

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007

Year

0

1

2

3

4

5

Nu

mb

er o

f C

ases

Per

cen

t o

f C

ases

Number of Cases Percent of Cases

Figure 8. Tuberculosis Cases by Verification Criteria: California, 2007

Provider Diagnosis201 (7.4%)

Positive Culture2,189 (80.3%)

Clinical Case326 (12.0%)

Positive Smear9 (0.3%)

Figure 9. Deaths in Persons with Tuberculosis: California, 1996-2005

0

100

200

300

400

500

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005

Year

0

2

4

6

8

10

12

Per

cen

t o

f C

ases

Nu

mb

er o

f D

eath

s

Dead at Diagnosis

Died During Treatment Died Before Starting Treatment

Percent Dying with Tuberculosis

Figure 10. Tuberculosis Cases by AIDS Diagnosis*: California, 1995-2004

0

100

200

300

400

500

1995 1996 1997 1998 1999 2000 2001 2002 2003 2004

Year

0

2

4

6

8

10

Nu

mb

er o

f C

ases

wit

h A

IDS

Per

cen

t o

f C

ases

wit

h A

IDS

* Match found in AIDS Case Registry, California Office of AIDS.

Number of Tuberculosis Cases with AIDSPercent of Tuberculosis Cases with AIDS

Figure 11. AIDS-associated Tuberculosis* by Race/Ethnicity: California, 1995-2004

0

25

50

75

100

125

150

175

200

1995 1996 1997 1998 1999 2000 2001 2002 2003 2004

Year

Nu

mb

er o

f C

ases

wit

h A

IDS

Hispanic

Black

White

Asian/Pacific Islander

American Indian/Alaska Native

* Match found in AIDS Case Registry, California Office of AIDS.

0

10

20

30

40

50

60

Initial Susceptibility Test Final Susceptibility Test

Figure 12. Tuberculosis Cases with Multidrug-resistance (MDR) on Initial or Final Drug

Susceptibility Testing*: California, 1996-2005N

um

ber

of

MD

R T

ub

ercu

losi

s C

ases

*Cases with resistance to at least isoniazid and rifampin reported on the Initial Drug Susceptibility Report (Follow-up 1) or on the Case Completion Report (Follow-up 2).

48 47

3942

35

3843

34

41

35

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005

Figure 13. Tuberculosis Cases with Initial Multidrug-resistance (MDR)*: California, 2003-2007

*Cases with initial drug resistance to at least isoniazid and rifampin.

Long BeachPasadena

BerkeleySan Francisco

25 Cases

15-24 Cases

5-14 Cases

1-4 Cases

None

Initial MDR Cases:2003-2007

Figure 14. Tuberculosis Cases1 by Outcome of Therapy: California, 2005

Completed Therapy 12 Months1,975 (70.0%)

Completed Therapy >12 Months315 (11.2%)

Moved2

219 (7.8%)

Died204 (7.2%)

Lost3

37 (1.3%) Refused16 (0.6%)

Other15 (0.5%)

1 Patient alive at diagnosis and started on an initial drug regimen of one or more drugs.2 Patient moved to another jurisdiction with a known forwarding address before treatment was completed.3 Patient could not be located prior to the completion of treatment.

No Info42 (1.5%)

Figure 15. Outcome in Tuberculosis Cases for Whom One Year or Less of Treatment was

Indicated1: California, 2005

Completed Therapy 12 Months1,964 (71.8%)

Completed Therapy >12 Months274 (10.0%)

Moved2

207 (7.6%)

Died191 (7.0%)

Lost3

37 (1.4%)

Refused15 (0.5%)

Other15 (0.5%)

NoInformation 34 (1.2%)

1 Excludes cases with rifampin resistant disease, cases with meningeal disease, and cases less than 15 years of age with disseminated tuberculosis disease.2 Moved to another jurisdiction with a known forwarding address before treatment was completed.3 Patient could not be located prior to the completion of treatment.

Completed Therapy 12 Months11 (12.8%)

Completed Therapy >12 Months41 (47.7%)

Moved2

12 (14.0%)

Died13 (15.1%)

NoInformation 8 (9.3%)

1Includes cases with rifampin resistant disease, cases with meningeal disease, and cases less than 15 years of age with disseminated tuberculosis disease.

2 Patient moved to another jurisdiction with a known forwarding address before treatment was completed.3 Patient could not be located prior to the completion of treatment.

Refused1 (1.2%)

Figure 16. Outcome in Tuberculosis Cases for Whom Greater than One Year of

Treatment was Indicated1: California, 2005

Figure 17. Completion of Tuberculosis Therapy: California,1996-2005

0

20

40

60

80

100

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005Per

cen

t o

f C

ases

Co

mp

leti

ng

Th

erap

y

CompletedCompleted in 1 year or less

Note: Excludes cases with rifampin resistant disease, cases with meningeal disease, cases less than 15 years of age with disseminated tuberculosis disease, and those that died during treatment.

Recommended